Joachim H. Ix, MD, and Biff Palmer, MD, provide their perspectives on the clinical impact of 8 recently published studies involving the management of patients with Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Drs. Palmer and Ix will summarize the latest research developments on the pathogenesis of CKD-MBD and assess the clinical implications of recent data and evidence-based research involving various classes of phosphate binders, as well as calcimimetics and other agents for the treatment of secondary hyperparathyroidism, and lowering serum phosphate levels, to manage patients with CKD-MBD in clinical practice.
This activity was developed for nephrologists, primary care physicians, and other health care professionals who have an interest in chronic kidney disease-mineral and bone disorder (CKD-MBD).
|Available Credit:||2.00 AMA PRA Category 1 Credits™.|
|Opens:||June 26, 2017|
|Expires:||June 25, 2018|
Primary Care Physicians
Other Health Care Providers